Literature DB >> 11845236

Reduced lipolysis as possible cause for greater weight gain in subjects with the Pro12Ala polymorphism in PPARgamma2?

Michael Stumvoll, H Häring.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11845236     DOI: 10.1007/s125-002-8257-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  10 in total

1.  Influence of Pro12Ala peroxisome proliferator-activated receptor gamma2 polymorphism on glucose response to exercise training in type 2 diabetes.

Authors:  K B Adamo; R J Sigal; K Williams; G Kenny; D Prud'homme; F Tesson
Journal:  Diabetologia       Date:  2005-06-29       Impact factor: 10.122

2.  Combined effects of PPARgamma2 P12A and PPARalpha L162V polymorphisms on glucose and insulin homeostasis: the Québec Family Study.

Authors:  Yohan Bossé; S John Weisnagel; Claude Bouchard; Jean-Pierre Després; Louis Pérusse; Marie-Claude Vohl
Journal:  J Hum Genet       Date:  2003-11-20       Impact factor: 3.172

3.  Genotype Phenotype Correlation of Genetic Polymorphism of PPAR Gamma Gene and Therapeutic Response to Pioglitazone in Type 2 Diabetes Mellitus- A Pilot Study.

Authors:  S Shanmuga Priya; Ramalingam Sankaran; Sudha Ramalingam; Thiagarajan Sairam; L S Somasundaram
Journal:  J Clin Diagn Res       Date:  2016-02-01

4.  Assessment of the Pro12Ala Polymorphism in the PPAR-γ2 Gene among Type 2 Diabetes Patients in a Nigerian Population.

Authors:  Godwill Azeh Engwa; Friday Nweke Nwalo; Venatus Osita Chiezey; Marian N Unachukwu; Opeolu Oyejide Ojo; Benjamin Ewa Ubi
Journal:  J Clin Med       Date:  2018-04-05       Impact factor: 4.241

5.  Peroxisome Proliferator-Activated Receptor-γ Gene Polymorphism in Psoriasis and Its Relation to Obesity, Metabolic Syndrome, and Narrowband Ultraviolet B Response: A Case-Control Study in Egyptian Patients.

Authors:  Iman Seleit; Ola Ahmed Bakry; Eman Abd El Gayed; Mai Ghanem
Journal:  Indian J Dermatol       Date:  2019 May-Jun       Impact factor: 1.494

6.  Association of Pro12Ala polymorphism in peroxisome proliferator activated receptor gamma with proliferative diabetic retinopathy.

Authors:  Khadija Tariq; Saira Bano Malik; Syeda Hafiza Benish Ali; Sundas Ejaz Maqsood; Aisha Azam; Irfan Muslim; Muhammad Shakil Khan; Maleeha Azam; Nadia Khalida Waheed; Raheel Qamar
Journal:  Mol Vis       Date:  2013-03-21       Impact factor: 2.367

7.  PPARγ2 polymorphism and human health.

Authors:  Weimin He
Journal:  PPAR Res       Date:  2009-04-16       Impact factor: 4.964

8.  Genetic prediction of future type 2 diabetes.

Authors:  Valeriya Lyssenko; Peter Almgren; Dragi Anevski; Marju Orho-Melander; Marketa Sjögren; Carola Saloranta; Tiinamaija Tuomi; Leif Groop
Journal:  PLoS Med       Date:  2005-11-01       Impact factor: 11.069

9.  Does Pro(12)Ala Polymorphism Enhance the Physiological Role of PPARγ2?

Authors:  A C Pereira; R Oliveira; A C Castro; R Fernandes
Journal:  PPAR Res       Date:  2013-07-31       Impact factor: 4.964

10.  Peroxisome proliferator-activated receptor gamma (PPARG) modulates free fatty acid receptor 1 (FFAR1) dependent insulin secretion in humans.

Authors:  Robert Wagner; Anja Hieronimus; Apostolia Lamprinou; Martin Heni; Erifili Hatziagelaki; Susanne Ullrich; Norbert Stefan; Harald Staiger; Hans-Ulrich Häring; Andreas Fritsche
Journal:  Mol Metab       Date:  2014-07-07       Impact factor: 7.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.